Atricure Stock Market Value
| ATRC Stock | USD 35.68 0.35 0.97% |
| Symbol | AtriCure |
AtriCure Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.82) | Revenue Per Share 9.564 | Quarterly Revenue Growth 0.179 | Return On Assets (0.04) | Return On Equity (0.08) |
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
AtriCure 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AtriCure's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AtriCure.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in AtriCure on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding AtriCure or generate 0.0% return on investment in AtriCure over 30 days. AtriCure is related to or competes with Nexgel, Avinger, Sharps Technology, Microbot Medical, Pro Dex, JIN MEDICAL, and Meihua International. AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and in... More
AtriCure Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AtriCure's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AtriCure upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.92 | |||
| Information Ratio | 0.1924 | |||
| Maximum Drawdown | 23.09 | |||
| Value At Risk | (3.12) | |||
| Potential Upside | 4.67 |
AtriCure Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AtriCure's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AtriCure's standard deviation. In reality, there are many statistical measures that can use AtriCure historical prices to predict the future AtriCure's volatility.| Risk Adjusted Performance | 0.1759 | |||
| Jensen Alpha | 0.5632 | |||
| Total Risk Alpha | 0.3278 | |||
| Sortino Ratio | 0.3067 | |||
| Treynor Ratio | 0.514 |
AtriCure Backtested Returns
AtriCure appears to be very steady, given 3 months investment horizon. AtriCure secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17% return per unit of risk over the last 3 months. By analyzing AtriCure's technical indicators, you can evaluate if the expected return of 0.54% is justified by implied risk. Please makes use of AtriCure's Mean Deviation of 1.92, downside deviation of 1.92, and Risk Adjusted Performance of 0.1759 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, AtriCure holds a performance score of 13. The firm shows a Beta (market volatility) of 1.31, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AtriCure will likely underperform. Please check AtriCure's downside variance, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether AtriCure's price patterns will revert.
Auto-correlation | -0.74 |
Almost perfect reverse predictability
AtriCure has almost perfect reverse predictability. Overlapping area represents the amount of predictability between AtriCure time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AtriCure price movement. The serial correlation of -0.74 indicates that around 74.0% of current AtriCure price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.74 | |
| Spearman Rank Test | -0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 1.06 |
AtriCure lagged returns against current returns
Autocorrelation, which is AtriCure stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting AtriCure's stock expected returns. We can calculate the autocorrelation of AtriCure returns to help us make a trade decision. For example, suppose you find that AtriCure has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
AtriCure regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If AtriCure stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if AtriCure stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in AtriCure stock over time.
Current vs Lagged Prices |
| Timeline |
AtriCure Lagged Returns
When evaluating AtriCure's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of AtriCure stock have on its future price. AtriCure autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, AtriCure autocorrelation shows the relationship between AtriCure stock current value and its past values and can show if there is a momentum factor associated with investing in AtriCure.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:Check out AtriCure Correlation, AtriCure Volatility and AtriCure Alpha and Beta module to complement your research on AtriCure. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
AtriCure technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.